Russian Pharmaceutical Industry Leader
About
Products
Press center
R&D
Career
Antifraud
Export
Contacts
News
Media publications
Information materials
Terms of use
Home
Press center
News
Аll
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
BratskChemSyntez
Export
Аll
2025
2024
2023
2022
2021
2020
2019
2018
2017
22.12.2023
Opening of a physiotherapy room in Chuna District Hospital with the participation of the Pharmasyntez Group of Companies
Read more
22.12.2023
Pharmasyntez-Nord receives ANVISA GMP certification in Brazil
Read more
22.12.2023
The Pharmasyntez Group of Companies made the first delivery of antineoplastic drugs to the Republic of the Union of Myanmar
Read more
19.12.2023
The Pharmasyntez Group of Companies ranked one of the top 3 fast-growing companies in the pharmaceutical market
Read more
15.12.2023
The Pharmasyntez Group of Companies established a personal scholarship for the tobogganist Semyon Pavlichenko
Read more
13.12.2023
The Pharmasyntez-Tyumen plant held an excursion for the students of the Tyumen State University
Read more
11.12.2023
Chief Executive Officer of Pharmasyntez-Nord is the leader of the rating in the Pharmaceutical Industry nomination
Read more
06.12.2023
Etorelex® drug is the winner of Russian Pharma Awards® 2023
Read more
05.12.2023
Nomides in new packages with a height chart
Read more
04.12.2023
Badge of Honor for “Investor of the Year” went to Pharmasyntez-Nord
Read more
28.11.2023
The Pharmasyntez Group of Companies will continue to support judo player Alesya Kuznetsova in 2024
Read more
27.11.2023
The first commercial batch of peritoneal dialysis solutions produced by the Pharmasyntez Group of Companies was released into civil commerce
Read more
20.11.2023
The Pharmasyntez Group of Companies participated in the International RUSSIA EXPO
Read more
17.11.2023
The Pharmasyntez Group of Companies participated in the XXVII Russian Oncology Congress
Read more
15.11.2023
The Pharmasyntez Group of Companies released the first batch of the nootropic drug– Nooredit
Read more
14.11.2023
Bringing children to the workplace of parents
Read more
News:
← предыдущая
1
2
3
4
5
следующая →
About
History
Production
JSC Pharmasyntez
LLC EAST-PHARM
LLC PHARMASYNTEZ-TYUMEN
JSC PHARMASYNTEZ-NORD
LLC BratskChemSyntez
Quality management
Management
Social projects
Products
Anti-TB
Antibiotics
Cardiology
Corticoid hormones
COVID-19
Drugs for the treatment of diabetes mellitus
Endocrinology
Gynecology
HIV treatment
Infusion solutions
Injectable solutions
Local anesthetic agents
MRI agents
Multiple sclerosis
Neuroleptics
Neurology
Nonsteroidal anti-inflammatory drug
Nootropics
Oncology
Systemic mycoses
Therapeutic drugs
Transplantology
Treatment of hepatitis B
X-ray contrast agents
Сообщить о нежелательном явлении
Заполнить анкету по качеству
Press center
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
BratskChemSyntez
Export
R&D
R&D co-operation
Intellectual property
Publications
Career
Personnel policy
Training and career development
Antifraud
Export
Possibilities
News
Contacts
Head office
Moscow Office
East-Pharm
Pharmasyntez-Tyumen
Pharmasyntez-Nord
BratskChemSyntez